Journal
JOURNAL OF LIPID RESEARCH
Volume 50, Issue -, Pages S29-S34Publisher
ELSEVIER
DOI: 10.1194/jlr.R800042-JLR200
Keywords
prostaglandin; endocannabinoid; inflammation; nonsteroidal anti-inflammatory; coxib; hydroperoxide; arachidonic acid; essential fatty acid
Categories
Funding
- National Institutes of Health [CA-89450, GM-15431]
Ask authors/readers for more resources
Cyclooxygenase (COX; prostaglandin G/H synthase, EC 1.14.99.1) catalyzes the first two steps in the biosynthesis of prostaglandins (PGs). The two COX isoforms COX-1 and COX-2 are the targets of the widely used nonsteroidal anti-inflammatory drugs, indicating a role for these enzymes in pain, fever, inflammation, and tumorigenesis. The ubiquitous constitutive expression of COX-1 and inducible expression of COX-2 have led to the widely held belief that COX-1 produces homeostatic PGs, while PGs produced by COX-2 are primarily pathophysiological. However, recent discoveries call this paradigm into question and reveal as yet underappreciated functions for both enzymes.jlr This review focuses on some of these new insights.-Rouzer, C. A., and L. J. Marnett. Cyclooxygenases: structural and functional insights. J. Lipid Res. 2009. S29-S34.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available